Euglycemic Ketoacidosis in a non-diabetic patient: a rare adverse effect of sodium-glucose co-transporter type-2 inhibitors. A review based on a case report
Sodium-glucose co-transporter type-2 (SGLT-2) inhibitors (SGLT2i) are increasingly used in clinical practice, with proven benefits in chronic conditions such as diabetes mellitus, heart failure (HF), and chronic kidney disease. Prescription of SGLT2i is a common practice among healthcare providers....
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Permanyer
2025-01-01
|
| Series: | Nefrología Latinoamericana |
| Subjects: | |
| Online Access: | https://www.nefrologialatinoamericana.com/frame_eng.php?id=166 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|